These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15904995)

  • 1. The effects of APOE and tau gene variability on risk of frontotemporal dementia.
    Bernardi L; Maletta RG; Tomaino C; Smirne N; Di Natale M; Perri M; Longo T; Colao R; Curcio SA; Puccio G; Mirabelli M; Kawarai T; Rogaeva E; St George Hyslop PH; Passarino G; De Benedictis G; Bruni AC
    Neurobiol Aging; 2006 May; 27(5):702-9. PubMed ID: 15904995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between tau H2 haplotype and age at onset in frontotemporal dementia.
    Borroni B; Yancopoulou D; Tsutsui M; Padovani A; Sawcer SJ; Hodges JR; Spillantini MG
    Arch Neurol; 2005 Sep; 62(9):1419-22. PubMed ID: 16157749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The H2 MAPT haplotype is associated with familial frontotemporal dementia.
    Ghidoni R; Signorini S; Barbiero L; Sina E; Cominelli P; Villa A; Benussi L; Binetti G
    Neurobiol Dis; 2006 May; 22(2):357-62. PubMed ID: 16410051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E epsilon4 frequency, but no tau gene mutations.
    Fabre SF; Forsell C; Viitanen M; Sjögren M; Wallin A; Blennow K; Blomberg M; Andersen C; Wahlund LO; Lannfelt L
    Exp Neurol; 2001 Apr; 168(2):413-8. PubMed ID: 11259129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
    Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
    Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association of APOE and tau polymorphisms with dementia in Parkinson's disease.
    Ezquerra M; Campdelacreu J; Gaig C; Compta Y; Muñoz E; Martí MJ; Valldeoriola F; Tolosa E
    Neurosci Lett; 2008 Dec; 448(1):20-3. PubMed ID: 18930114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
    Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
    Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E epsilon4 allele has no effect on age at onset or duration of disease in cases of frontotemporal dementia with pick- or microvacuolar-type histology.
    Pickering-Brown SM; Owen F; Isaacs A; Snowden J; Varma A; Neary D; Furlong R; Daniel SE; Cairns NJ; Mann DM
    Exp Neurol; 2000 Jun; 163(2):452-6. PubMed ID: 10833320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Education plays a different role in Frontotemporal Dementia and Alzheimer's disease.
    Borroni B; Alberici A; Agosti C; Premi E; Padovani A
    Int J Geriatr Psychiatry; 2008 Aug; 23(8):796-800. PubMed ID: 18172915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis of MAPT haplotype diversity in frontotemporal dementia.
    Laws SM; Friedrich P; Diehl-Schmid J; Müller J; Ibach B; Bäuml J; Eisele T; Förstl H; Kurz A; Riemenschneider M
    Neurobiol Aging; 2008 Aug; 29(8):1276-8. PubMed ID: 17386961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia.
    Engelborghs S; Dermaut B; Mariën P; Symons A; Vloeberghs E; Maertens K; Somers N; Goeman J; Rademakers R; Van den Broeck M; Pickut B; Cruts M; Van Broeckhoven C; De Deyn PP
    Neurobiol Aging; 2006 Feb; 27(2):285-92. PubMed ID: 16399213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOE-related mortality: effect of dementia, cardiovascular disease and gender.
    Rosvall L; Rizzuto D; Wang HX; Winblad B; Graff C; Fratiglioni L
    Neurobiol Aging; 2009 Oct; 30(10):1545-51. PubMed ID: 18237822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic interaction between tau and the apolipoprotein E receptor LRP1 Increases Alzheimer's disease risk.
    Vázquez-Higuera JL; Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Pozueta A; Infante J; Berciano J; Combarros O
    Dement Geriatr Cogn Disord; 2009; 28(2):116-20. PubMed ID: 19684401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of tau genotype on clinical features in FTDP-17.
    Baba Y; Tsuboi Y; Baker MC; Uitti RJ; Hutton ML; Dickson DW; Farrer M; Putzke JD; Woodruff BK; Ghetti B; Murrell JR; Boeve BF; Petersen RC; Verpillat P; Brice A; Delisle MB; Rascol O; Arima K; Dysken MW; Yasuda M; Kobayashi T; Sunohara N; Komure O; Kuno S; Sperfeld AD; Stoppe G; Kohlhase J; Pickering-Brown S; Neary D; Bugiani O; Wszolek ZK
    Parkinsonism Relat Disord; 2005 Jun; 11(4):205-8. PubMed ID: 15878580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of apolipoprotein E and cognitive function in old age.
    Mooijaart SP; van Vliet P; van Heemst D; Rensen PC; Berbée JF; Jolles J; de Craen AJ; Westendorp RG
    Ann N Y Acad Sci; 2007 Apr; 1100():148-61. PubMed ID: 17460173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel tau polymorphisms, tau haplotypes, and splicing in familial and sporadic frontotemporal dementia.
    Sobrido MJ; Miller BL; Havlioglu N; Zhukareva V; Jiang Z; Nasreddine ZS; Lee VM; Chow TW; Wilhelmsen KC; Cummings JL; Wu JY; Geschwind DH
    Arch Neurol; 2003 May; 60(5):698-702. PubMed ID: 12756133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effects of apoE-CI-CII cluster and LDL-R gene polymorphisms on chromosome 19 and coronary artery disease risk.
    Wang C; Zhou X; Ye S; Han D; Tan X; Zheng F; Shi Q
    Int J Hyg Environ Health; 2006 May; 209(3):265-73. PubMed ID: 16459141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide.
    Benussi L; Ghidoni R; Pegoiani E; Moretti DV; Zanetti O; Binetti G
    Neurobiol Dis; 2009 Mar; 33(3):379-85. PubMed ID: 19101631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of MAPT and APOE on prognosis of progressive supranuclear palsy.
    Baba Y; Putzke JD; Tsuboi Y; Josephs KA; Thomas N; Wszolek ZK; Dickson DW
    Neurosci Lett; 2006 Sep; 405(1-2):116-9. PubMed ID: 16839689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of apolipoprotein E on dementia in persons with Down's syndrome.
    Coppus AM; Evenhuis HM; Verberne GJ; Visser FE; Arias-Vasquez A; Sayed-Tabatabaei FA; Vergeer-Drop J; Eikelenboom P; van Gool WA; van Duijn CM
    Neurobiol Aging; 2008 Jun; 29(6):828-35. PubMed ID: 17250929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.